Top Banner
Item BOARD OF DIRECTORS OPERATIONAL PERFORMANCE REPORT Presented By: 17th December 2015 Board of Directors Produced By: Stephen Chinn Senior Performance Analyst John Quinn Chief Operating Officer (Produced on 11th December 2015) Month 8 (November 2015) Action for Board: For information For consideration For decision
17

Item - Moorfields Eye Hospital · Compared to 2014/15, November activity was up 7% (vs. November 2014) with the YTD up 9%. Cancer Performance For November 2015 '2 week wait' performance

Oct 22, 2020

Download

Documents

dariahiddleston
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
  • Item

    BOARD OF DIRECTORS OPERATIONAL PERFORMANCE REPORT

    Presented By:

    17th December 2015

    Board of Directors

    Produced By:

    Stephen Chinn

    Senior Performance Analyst

    John Quinn

    Chief Operating Officer

    (Produced on 11th December 2015)

    Month 8 (November 2015)

    Action for Board: For information

    For consideration

    For decision

  • Board of Directors Performance Report - November 2015

    Exception Report Page 2 - 3

    Compliance Performance Summary Page 4

    Access - Referral to Treatment Page 5 - 6

    Access - A&E Page 7 - 8

    Access - Cancer Waiting Times Page 9

    Access - Other Page 10

    Efficiency Page 11 -12

    Effectiveness Page 13

    Safety Page 13

    Ward Staffing Levels Page 14

    Patient Experience Page 15

    Bank and Agency Staff Information Page 16

    CONTENTS

    For decision

    Page 1

  • Board of Directors Performance Report - November 2015

    Exception Report - November 2015

    RTT Performance

    The October 2015 figures within this report are now confirmed, there were no significant changes to the provisional figures reported.

    From October 2015, RTT reporting has changed to focus on open (incomplete) pathways or how long untreated patients are waiting. NHS Hospitals are no longer submitting 'closed' admitted and non-admitted data however this is still being monitored locally.

    Two new RTT measures have been introduced nationally and are included in this report, these are: • 18 weeks Referral to Treatment -Incomplete (Pathways with DTA) • New RTT Periods - All Patients (Number of new Pathways)

    RTT Incomplete Performance for November 2015 saw an increase to 95.1% (M7 - October 2015: 94.7%) with the Year to Date at 94.0%, remaining above the 92% target

    18 weeks Referral to Treatment -Incomplete (Pathways with DTA) performance was at 87.1%, a decrease from 88.2% in October 2015. At this time figures prior to October 2015 are unavailable , this will be updated for the next report.

    There were no 52 week breaches reported in November 2015. Accident and Emergency

    In November 2015, the A&E department remained in a challenging position due to periods of high activity. November performance was achieved, however it was the second lowest recorded at 95.8% (M7: 95.7%), with 340 four hour breaches, however there was a reduction in the number of six hour breaches at 11 (M7: 30). The YTD four hour position is at 97.4%.

    Three hour performance was also low, with the trust achieving 76.0% for the month (M6: 75.7%) with a YTD of 77.4%.

    The challenges facing the A&E department have been recognised, and an A&E Active Triage pilot has been approved to allow A&E patients to be seen in different settings in order to ease the demand pressures on the department. This is due to commence early in the New Year.

    Longer and more substantive changes are expected with the acceleration of the remainder of the A&E service review, with particular emphasis on medical staffing.

    A&E Activity continues to remain high although not as high as the record levels experienced during Quarter 1. Compared to 2014/15, November activity was up 7% (vs. November 2014) with the YTD up 9%. Cancer Performance

    For November 2015 '2 week wait' performance was at 80%; we had one breach for Ocular Oncology, due to patient choice. The YTD is at 90.9%, below the 93% target

    'Cancer 31 day wait - diagnosis to first appointment' was at 89.5% for November 2015 with the YTD at 93.8%, both below the 96% target. Both breaches were for Ocular Oncology: • Patient 1: Patient choice first, then patient cancelled surgery because unwell. • Patient 2: The operation was cancelled because patient was admitted as an inpatient at North Middlesex Hospital for another condition.

    'Cancer 31 day wait - subsequent treatment - surgery' was at 100% for the month, but remains below the 94% target for the YTD at 89.5%.

    Page 2

  • Board of Directors Performance Report - November 2015

    Exception Report - November 2015 (Continued)

    Choose and Book Performance Following the transition from the CAB system to e-Referral system the reports module of the new e-Referral system was not implemented before go-live. We have been informed by the e-Referral Team at HSCIC that the reports module which includes the Weekly ASI (Appointment Slot Issue) Report will be unavailable until further notice, therefore these figures will be unavailable until the reports module has been implemented by the HSCIC. This report contains data up to the last full month available (May 2015). Outpatient and Admission Activity First Appointment Activity remains high compared to the previous year, up 8% compared to November 2014 and 12% for the year to date . Follow up activity was at a similar level compared to November 2014 (per working day) and 3% up for the YTD.

    Admission activity continues to see a decrease in admissions compared to last year, and is down 10% compared to November 2014, which is the equivalent of 15 less operations per working day. Year to date is down by 7%. Mixed Sex Accommodation Breaches Last month, Moorfields recorded 23 Mixed Sex Accommodation breaches, all of which occurred in one of our wards. The increase in MSA breaches was due to a number of patients admitted who required complex treatment, such as intensive treatment for eye infections (resulting in long term use of the two side rooms). There were also a number of patients admitted with longer term care needs that required admission and overnight stay. Work is underway to improve the current ward layout. Bank and Agency Staff Information At the time of the publication of this report the November Data is not yet available. The data contained in this report is therefore the latest graph from October's report.

    Page 3

  • Board of Directors Performance Report - November 2015

    COMPLIANCE PERFORMANCE SUMMARY

    Threshold Nov-15 YTD 15/16Monthly

    TrendSource Threshold Nov-15 YTD 15/16

    Monthly

    TrendSource

    ≥ 90% 85.9% 89.96% CQC, Monitor,TDA ≥ 99% 100% 100% CQC, TDA

    ≥ 95% 95.5% 96.3% CQC, Monitor,TDA n/a 88.1% 88.0% Local

    ≥ 92% 95.1% 94.0% CQC, Monitor,TDA ≥ 96% n/a 85.3% Local

    n/a 87.1% 87.6% * CQC, Monitor,TDA 0 0 1 CQC, TDA

    n/a 11,407 22970 * CQC, Monitor,TDA n/a 2.1% 4.4% Monitor

    0 0 0 CQC, Monitor,TDA n/a 2.6% 4.7% CQC, TDA, Outcomes

    Framework

    0 0 2 CQC, Monitor,TDA n/a 45.6% 51.3% Local

    0 0 2 CQC, Monitor,TDA 0 0 0 CQC, Monitor,TDA

    ≥ 95% 95.8% 97.4% CQC, Monitor,TDA 0 0 0 CQC, Monitor,TDA

    ≥ 80% 76.0% 77.4% Local ≥ 95% 98.2% 98.3% CQC, TDA

    ≤ 5% 2.8% 2.5% CQC, TDA 0 23 30 CQC, TDA

    ≥ 30% 20.4% 22.8% Local n/a 103.0% 98.5% CQC, TDA

    ≤ 5% 0.3% 0.4% CQC, TDA ≥ 20% 14.7% 20.4% CQC,TDA, Outcomes

    Framework

    ≥ 93% 80.0% 90.9% CQC, Monitor,TDA ≥ 30% 53.8% 54.4% CQC,TDA, Outcomes

    Framework

    ≥ 96% 89.5% 93.8% CQC, Monitor,TDA ≥ 15% 10.7% 9.9% Local

    ≥ 94% 100.0% 89.5% CQC, Monitor,TDA

    ≥ 85% n/a 100.0% w CQC, Monitor,TDA

    Key Reference:

    w

    Performance 2015/16Performance 2015/16

    Percentage 18 weeks Non Admitted

    Pathways

    Emergency Readmissions within 28

    days of discharge

    Percentage 18 weeks Incomplete

    Pathways

    Emergency Readmissions within 30

    days of discharge

    Indicator Indicator

    Percentage 18 weeks Admitted

    Pathways

    Cancelled Operations - 28 Days Re-

    Book

    18 weeks Referral to Treatment -

    Incomplete (Pathways with DTA)

    New RTT Periods - All Patients

    18 weeks Admitted Pathways

    52 Week Breaches

    Choose & Book Appointment

    Availability (April & May 15 Only)

    Diagnostics 6 week waiting time

    18 weeks Incomplete Pathways

    52 Week BreachesNumber of MRSA cases

    Outpatient appointment - Over 6

    week waiters

    Cancer 2 week wait - first

    appointment urgent GP referral

    % Cancer 31 day wait - diagnosis to

    first appointment

    A&E Left Before Treatment

    A&E ENP Pathways

    A&E Unplanned re-attendance

    Friends & Family Test - Inpatients

    (Response Rate)

    18 weeks Non Admitted Pathways

    52 Week Breaches

    GP referrals first outpatient using

    Choose & Book

    VTE Screening - all admissions

    Number of Mixed Sex

    Accommodation Breaches

    Friends & Family Test - A&E

    (Response Rate)

    A&E 3 hour waiting times

    A&E 4 hour waiting time Number of C.Diff cases

    Ward Staffing Levels

    (Inpatient Wards Only)

    Within tolerance and drop in figures

    No target or N/A

    On or above target

    Stable on/above target

    On target and drop in figures

    Within tolerance and stable

    Within tolerance and rise in figures

    Friends & Family Test - Outpatients

    (Response Rate - Estimated)

    Below target and rise in figures

    Below target and stable

    Below target and fall in figures

    Cancer 31 day wait - subsequent

    treatment - surgery

    Cancer 62 day from urgent GP

    referral to first definitive treatment

    * Incomplete (Pathways with DTA) & New RTT Periods

    YTD from October 2015 as figures prior to this date available at this time

    Page 4

  • Board of Directors Performance Report - November 2015

    18 Weeks Referral to Treatment (Provisional)

    Year End YTD

    Current

    Month

    Previous

    Month Qtr1 Qtr2 Qtr3 Qtr4 YTD

    ≥ 90% 86.2% 83.7% 85.9% 88.5% 91.5% 90.2% 87.2% 89.96% Monitor, CQC,

    TDA

    ≥ 95% 95.1% 94.8% 95.6% 96.0% 96.9% 96.1% 95.8% 96.3% Monitor, CQC,

    TDA

    ≥ 92% 93.7% 92.9% 95.1% 94.7% 93.8% 93.5% 94.9% 94.0% Monitor, CQC,

    TDA

    N/A n/a n/a 87.1% 88.2% n/a n/a 87.7% 87.7% Monitor, CQC,

    TDA

    N/A n/a n/a 11,407 11,563 n/a n/a 22,970 22,970 Monitor, CQC,

    TDA

    Year End YTD

    Current

    Month

    Previous

    Month Qtr1 Qtr2 Qtr3 Qtr4 YTD

    0 2 1 0 0 0 0 0 0

    N/A 4,303 3,433 353 293 659 758 646 2,063

    N/A -1,191 -1,329 -104 -40 118 16 -143 -8

    0 3 2 0 0 1 1 0 2

    N/A 3,719 2,633 333 316 638 817 649 2,104

    N/A 77 -94 43 79 381 223 123 727

    0 7 5 0 0 2 0 0 2

    N/A 16,394 12,051 1,192 1,268 4,604 4,958 2,460 12,022

    N/A 4,426 1,591 758 663 1,329 1,189 1,421 3,940

    0 n/a n/a 0 0 n/a n/a 0 0 *

    N/A n/a n/a 470 411 n/a n/a 881 881 *

    * Incomplete (Pathways with DTA) & New RTT Periods: YTD from October 2015 as figures prior to this date available at this time

    52 Week RTT Breaches

    Non Admitted

    Incomplete

    (All Pathways)

    52 Week RTT Breaches

    18w(95%) Shortfall/Surplus

    52 Week RTT BreachesIncomplete

    (Pathways

    with DTA) * Patients Waiting >18 weeks

    Trust Total

    18 weeks Referral to Treatment -Non

    Admitted

    18 weeks Referral to Treatment -Incomplete

    (All Pathways)

    Indicator

    Patients Waiting >18 weeks

    18w(90%) Shortfall/Surplus

    Patients Waiting >18 weeks

    Indicator

    18 weeks Referral to Treatment - Admitted

    Admitted

    18 weeks Referral to Treatment -Incomplete

    (Pathways with DTA) *

    New RTT Periods - All Patients *

    Compliance

    Source

    Patients Waiting >18 weeks

    18w(92%) Shortfall/Surplus

    Monthly

    Trend

    Monthly

    TrendThreshold

    Performance 2015/16

    Threshold

    Performance 2015/16Performance 2014/15

    Performance 2014/15

    52 Week RTT Breaches

    Compliance

    Source

    Page 5

  • Board of Directors Performance Report - November 2015

    18 Weeks Referral to Treatment (Provisional) (Cont.)

    RTT Admitted Performance saw a slight decrease in performance, this was because of a concentrated focus applied due to the change of emphasis in RTT18 reporting on current

    long waiters and closing their pathways. In November Performance was 85.9% (M7: 88.5%). Year to Date at 89.96%.

    RTT Non-Admitted Performance saw an increase in performance in October achieving 95.5% (M7: 96.0%), with the Year to Date at 96.3%.

    Trust Total

    Page 6

  • Board of Directors Performance Report - November 2015

    Year End YTD

    Current

    Month

    Previous

    Month Qtr1 Qtr2 Qtr3 Qtr4 YTD

    N/A95,951 64,862 8,400 9,024 27,233 26,070 17,424 70,727

    N/A92,811 62,922 8,031 8,419 25,585 25,422 16,450 67,457

    ≥ 95% 99.2% 99.1% 95.8% 95.7% 98.0% 97.9% 95.7% 97.4% CQC, Monitor,

    TDA

    ≥ 80% 81.8% 81.5% 76.0% 75.7% 76.1% 79.8% 75.9% 77.4% Local

    N/A 605 459 340 383 489 543 723 1755

    N/A 30 30 11 30 4 29 41 74

    ≤ 5% 1.2% 1.1% 2.8% 2.8% 2.6% 2.2% 2.8% 2.5% CQC, Monitor,

    TDA

    ≤ 60 mins 25 21 32 30 29 25 31 0 CQC, TDA

    ≤ 240 mins 219 229 203 202 230 217 227 0 CQC, TDA

    ≤ 240 mins 227 221 237 236 229 228 237 0 CQC, TDA

    ≥ 30% 24.0% 24.6% 20.4% 19.8% 23.6% 23.9% 20.1% 22.8% Local

    ≤ 5% 0.6% 0.7% 0.3% 0.3% 0.5% 0.5% 0.3% 0.4% CQC, TDA

    A&E Four Hour Performance

    Threshold

    Performance 2015/16

    Total number of Arrivals in A&E

    Total number of Expected Arrivals in A&E

    Accident & Emergency

    Indicator

    Compliance

    Source

    Performance 2014/15

    Monthly

    Trend

    A&E Three Hour Performance

    Time to Treatment in Department - median

    Total number of 4 hour breaches

    Total number of 6 hour breaches

    Left without being seen

    Total time spent in A&E -Admitted 95th

    Percentile

    Total time spent in A&E - Non Admitted 95th

    Percentile

    A&E Unplanned Re-attendance

    A&E ENP Pathway

    Page 7

  • Board of Directors Performance Report - November 2015

    Percentage of Unplanned Re-Attendances and Left A&E Before Treatment remains stable compared to previous months.

    Accident & Emergency (Cont.)

    Page 8

  • Board of Directors Performance Report - November 2015

    Year End YTD

    Current

    Month

    Previous

    Month Qtr1 Qtr2 Qtr3 Qtr4 YTD

    Cases 29 22 5 9 7 12 14 33 ≥ 93% 93.1% 90.9% 80.0% 77.8% 100.0% 100.0% 78.6% 90.9% Cases 15 10 19 18 4 56 37 97 ≥ 96% 100.0% 100.0% 89.5% 100.0% 100.0% 92.9% 94.6% 93.8% Cases 3 2 2 3 5 9 5 19 ≥ 94% 100.0% 100.0% 100.0% 100.0% 100.0% 77.8% 100.0% 89.5% Cases 0 0 0 0 0 1 0 1 ≥ 85% n/a n/a n/a n/a n/a 100.0% n/a n/a 100.0%

    Cases 16 10 2 8 2 3 10 15 ≥ 93% 100.0% 100.0% 50.0% 75.0% 100.0% 100.0% 70.0% 80.0% Cases 0 0 17 18 3 50 35 88 ≥ 96% 88.2% 100.0% 100.0% 92.0% 94.3% 93.2% Cases 0 0 1 2 0 5 3 8 ≥ 94% 100.0% 100.0% n/a 60.0% 100.0% 75.0% Cases 0 0 0 0 0 0 0 0 ≥ 85%

    Cases 13 12 3 1 5 9 4 18 ≥ 93% 84.6% 83.3% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% Cases 15 10 2 0 1 6 2 9 ≥ 96% 100.0% 100.0% 100.0% n/a 100.0% 100.0% 100.0% 100.0%

    Cases 3 2 1 1 5 4 2 11 ≥ 94% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% Cases 0 0 0 0 0 1 0 1 ≥ 85% 100.0% 100.0%

    Cancer 31 day waits - subsequent treatment

    CQC, Monitor,

    TDA

    Cancer 31 day waits - diagnosis to first

    appointment

    CQC, Monitor,

    TDA

    CQC, Monitor,

    TDA

    CQC, Monitor,

    TDA

    Cancer 62 days from urgent GP referral to first

    definitive treatment

    Cancer 31 day waits - subsequent treatment

    Cancer 62 days from urgent GP referral to first

    definitive treatment

    CQC, Monitor,

    TDA

    Brain and Nervous System Tumours

    Cancer 2 week waits - first appointment urgent

    GP referral

    CQC, Monitor,

    TDA

    Cancer 31 day waits - diagnosis to first

    appointment

    CQC, Monitor,

    TDA

    Cancer 31 day waits - subsequent treatmentCQC, Monitor,

    TDA

    Cancer 62 days from urgent GP referral to first

    definitive treatment

    CQC, Monitor,

    TDA

    Skin Cancer

    Cancer 2 week waits - first appointment urgent

    GP referral

    CQC, Monitor,

    TDA

    CQC, Monitor,

    TDA

    CQC, Monitor,

    TDA

    Compliance

    Source

    Cancer Waiting Times

    Indicator

    Cancer 31 day waits - diagnosis to first

    appointment

    Cancer 2 week waits - first appointment urgent

    GP referral

    Threshold

    Performance 2015/16

    Monthly

    Trend

    Performance 2014/15

    Page 9

  • Board of Directors Performance Report - November 2015

    Year End YTD

    Current

    Month

    Previous

    Month Qtr1 Qtr2 Qtr3 Qtr4 YTD

    ≥ 99% 100% 100% 100% 100% 100% 100% 100% 100% CQC, TDA

    TBA 85.5% 85.6% 88.1% 87.9% 86.2% 89.7% 88.0% 88.0% Local

    TBA 33.8% 39.6% 24.9% 22.4% 19.1% 23.8% 23.7% 22.1% Local

    ≥ 96% 87.3% 86.4% n/a n/a 85.3% * n/a n/a n/a 85.3% * Local

    N/A 12.0% 12.8% n/a n/a 12.8% n/a n/a n/a 12.8% Local

    N/A 0.7% 0.8% n/a n/a 1.8% n/a n/a n/a 1.8% Local

    Access - Other (Cont.)

    Choose and Book System Issue Rate

    Indicator Threshold

    * Quarter 1 and YTD figure are to May 2015 as unavailable (See notes below)

    Diagnostic waiting times Performance remains at 100%.

    Both the percentage of patients waiting 6 weeks for a first appointment and those waiting for admission within 13 weeks has increased compared to the previous month.

    Following the transition from the CAB system to e-Referral system the reports module of the new e-Referral system was not implemented before go-live, therefore we are

    unable to report any recent Choose and Book Performance figures. The figures within this report are to May 2015.

    Choose and Book Capacity Issue Rate

    First Outpatient Appointment Waiting more

    than 6 weeks

    Patients Waiting more than 13 weeks for

    Admission

    Diagnostic waiting times - 6 weeks

    Choose and Book appointment availability

    Access - Other

    Monthly

    Trend

    Performance 2014/15

    Compliance

    Source

    Performance 2015/16

    Page 10

  • Board of Directors Performance Report - November 2015

    Year End YTD

    Current

    MonthPrevious

    Month Qtr1 Qtr2 Qtr3 Qtr4 YTD

    N/A 104,890 68,901 10,129 10,396 28,237 28,218 20,525 76,980 Local

    N/A 403,657 270,814 34,988 37,002 102,411 104,088 71,990 278,489 Local

    N/A 10.4% 9.4% 10.3% 10.5% 10.6% 10.5% 10.4% 10.5% Local

    N/A 11.6% 11.4% 13.0% 12.6% 11.7% 12.4% 12.8% 12.3% Local

    N/A 12.4% 12.2% 11.7% 11.9% 12.0% 12.3% 11.8% 12.0% Local

    N/A 56.7% 55.7% 55.7% 57.9% 57.1% 59.6% 56.8% 57.9% Local

    N/A 70.5% 70.2% 72.9% 72.2% 70.7% 72.6% 72.5% 71.9% Local

    N/A 36,500 23,967 3,104 3,098 9,405 9,219 6,202 24,826 Local

    N/A 37,232 25,577 2,877 2,977 8,987 8,929 5,854 23,770 Local

    N/A 6.2% 6.0% 7.9% 9.2% 6.6% 7.5% 8.6% 7.4% Local

    N/A 28.8% 26.7% 36.5% 37.3% 34.0% 33.6% 36.9% 34.6% Local

    0 3 3 0 0 1 0 0 1 CQC, TDA

    Efficiency

    Trust Total

    Outpatient DNA rate

    - First Appointment

    Theatre Sessions Starting Late

    Clinic Journey Times Less Than 2 Hours

    - Outpatient First Appointment

    Clinic Journey Times Less Than 2 Hours

    - Outpatient Follow Up Appointment

    Outpatient DNA rate

    - Follow Up Appointment

    Theatre Cancellation Rate

    Admission Demand

    - Decision to Admit (DTA)

    Admission Activity

    Outpatient Cancellations

    Outpatient Total Attendances

    - First Appointment

    Monthly

    Trend

    Compliance

    Source

    Performance 2015/16Performance 2014/15

    Outpatient Total Attendances

    - Follow Up Appointment

    Threshold

    Cancelled Operations - 28 Days Re-Book

    (Provisional)

    Page 11

  • Board of Directors Performance Report - November 2015

    Key:

    Efficiency (Cont.)

    There has been an increasing trend of First

    Appointment DNA Rate over the last 3

    months, increasing from 12% to 13%. DNA

    Rates for Follow Up Appointment have

    remained stable compared to previous

    months.

    :4 Month Average:Monthly Trend

    Page 12

  • Board of Directors Performance Report - November 2015

    Effectiveness

    Year End YTD

    Current

    MonthPrevious

    Month Qtr1 Qtr2 Qtr3 Qtr4 YTD

    N/A 3.8% 3.7% 2.1% 4.6% 4.7% 4.6% 3.5% 4.4% Monitor

    Cases 102 67 4 11 33 35 15 83

    N/A 4.1% 4.0% 2.6% 5.0% 5.0% 4.8% 3.9% 4.7% CQC, TDA

    Cases 109 71 5 12 35 37 17 89

    N/A 54% 54% 45.6% 50.7% 53.8% 51.3% 48.1% 51.3% Local

    Safety

    Year End YTD

    Current

    MonthPrevious

    Month Qtr1 Qtr2 Qtr3 Qtr4 YTD

    0 0 0 0 0 0 0 0 0 CQC, TDA,

    Monitor

    0 0 0 0 0 0 0 0 0 CQC, Monitor,

    TDA

    ≥ 95% 98.5% 98.4% 98.2% 96.7% 98.7% 98.5% 97.5% 98.3% CQC, TDA

    0 0 0 23 4 3 0 27 30 CQC, TDA

    Compliance

    SourceThreshold

    Monthly

    Trend

    Compliance

    Source

    Performance 2015/16Performance 2014/15

    Performance 2014/15

    Number of C.Diff cases

    Performance 2015/16

    Number of MRSA cases

    Indicator Threshold

    Emergency Re-admission within 28 days of

    discharge

    Emergency Re-admission with 30 days for

    elective and emergency cases

    % GP referrals From Electronic Booking

    (Choose & Book /E-referrals)

    Indicator

    VTE Screening

    Mixed Sex Accommodation (Provisional)

    Monthly

    Trend

    Page 13

  • Board of Directors Performance Report - November 2015

    Ward Staffing Levels (Only 'wards with inpatient beds' as per report requirement) - Provisional

    Page 14

  • Board of Directors Performance Report - November 2015

    Patient Experience - Friends and Family Test (FFT) - November Provisional

    Please note there have been a number of changes to the Friends and Family Test (FFT) response rate and scoring.

    The scoring system has been replaced with a simpler percentage method, where patients who are ‘Extremely likely’ or ‘Likely’ to recommend Moorfields to friends and family

    are listed as ‘Would Recommend’ the hospital, and patients who are ‘Unlikely’ or ‘Extremely Unlikely’ to recommend Moorfields are listed to ‘Would Not Recommend’ the

    hospital.

    The eligible patient population now includes under-16’s in all categories.

    The ‘Inpatient’ FFT responses now include ‘day case’ patients as well as patients who stayed overnight, which has increased the number of results received in this category.

    The ‘outpatient’ FFT scores and response rates are now also included in this report, covering most patients who attended an outpatient clinic.

    Accident and Emergency FFT response rate method remains unchanged from last year (aside from the aforementioned inclusion of under-16s).

    Page 15

  • Board of Directors Performance Report - November 2015

    Nursing Bank and Agency Staff Information (October Data)

    Proportion of Nursing Bank and Agency Staff Hours filled, with total hours worked

    Page 16